Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NITISINONE Cause Product availability issue? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product availability issue have been filed in association with NITISINONE (Nitisinone). This represents 0.8% of all adverse event reports for NITISINONE.

6
Reports of Product availability issue with NITISINONE
0.8%
of all NITISINONE reports
0
Deaths
4
Hospitalizations

How Dangerous Is Product availability issue From NITISINONE?

Of the 6 reports, 4 (66.7%) required hospitalization.

Is Product availability issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NITISINONE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does NITISINONE Cause?

Amino acid level increased (118) Liver transplant (62) Hepatocellular carcinoma (58) Cataract (47) Off label use (41) Alpha 1 foetoprotein increased (39) Lenticular opacities (34) Vomiting (32) Succinylacetone increased (31) Treatment noncompliance (30)

What Other Drugs Cause Product availability issue?

RUXOLITINIB (2,142) LISDEXAMFETAMINE DIMESYLATE (1,530) CERTOLIZUMAB PEGOL (1,381) VEDOLIZUMAB (636) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (610) METHYLPHENIDATE (444) SECUKINUMAB (399) BIMEKIZUMAB-BKZX (364) LACOSAMIDE (359) BRIVARACETAM (324)

Which NITISINONE Alternatives Have Lower Product availability issue Risk?

NITISINONE vs NITRAZEPAM NITISINONE vs NITRENDIPINE NITISINONE vs NITRIC NITISINONE vs NITROFURANTOIN NITISINONE vs NITROFURANTOIN\NITROFURANTOIN

Related Pages

NITISINONE Full Profile All Product availability issue Reports All Drugs Causing Product availability issue NITISINONE Demographics